Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
PaperCitations, authors & open-access status
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,773 citations, 2021 year and bronze oa status.
1,773
Citations
2021
Year
bronze
OA Status